Acquisitions and Strategic Investments (Tables)

9 Months Ended

Sep. 30, 2017

Business Acquisition [Line Items]

Business Combination, Components of Purchase Price [Table Text Block]

The components of the aggregate preliminary purchase price are as follows (in millions):

Payment for acquisition, net of cash acquired $ 392

Investment [Table Text Block]

The aggregate carrying amount of our strategic investments were comprised of the following categories:

	As of
(in millions)	September 30, 2017		December 31, 2016
Equity method investments	$	204	$	265
Cost method investments	69		20
Available-for-sale securities	32		20
Notes receivable	44		42
	$	349	$	347

Business Combination, Purchase Price Allocation Schedule [Table Text Block]

The following summarizes the preliminary purchase price allocation for the Symetis acquisition as of September 30, 2017

(in millions):

Goodwill	$	191
Amortizable intangible assets	278
Other assets acquired	26
Liabilities assumed	(103		)
	$	392

Business Acquisition, Purchase Price Allocation, Intangible Assets, Description [Table Text Block]

We allocated a portion of the purchase price to specific intangible asset categories as follows:

	Amount Assigned (in millions)		Amortization Period (in years)	Risk-Adjusted Discount Rates used in Purchase Price Allocation
Amortizable intangible assets:
Technology-related	$	268	13	24%
Other intangible assets	10		2-13	24%
	$	278

Rollforward of Fair Value of Contingent Consideration [Table Text Block]

Changes in the fair value of our contingent consideration liabilities were as follows (in millions):

Balance as of December 31, 2016	$	204
Fair value adjustments	(78		)
Contingent payments related to prior period acquisitions	(45		)
Balance as of September 30, 2017	$	81

Description of unobservable inputs used in Level 3 fair value measurements [Table Text Block]

The recurring Level 3 fair value measurements of our contingent consideration liabilities include the following significant unobservable inputs:

Contingent Consideration Liabilities	Fair Value as of September 30, 2017	Valuation Technique	Unobservable Input	Range
R&D and Commercialization-based Milestones	$31 million	Discounted Cash Flow	Discount Rate	2%
			Projected Year of Payment	2018 - 2021
Revenue-based Payments	$50 million	Discounted Cash Flow	Discount Rate	11% - 15%
			Projected Year of Payment	2017 - 2026